SVB Leerink Upgrades Epizyme (EPZM) to Outperform
Tweet Send to a Friend
SVB Leerink analyst Andrew Berens upgraded Epizyme (NASDAQ: EPZM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
